These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m Patel P; Oh AL; Koshy M; Sweiss K; Saraf SL; Quigley JG; Khan I; Mahmud N; Hacker E; Ozer H; Peace DJ; Weichselbaum RR; Aydogan B; Rondelli D Leuk Lymphoma; 2018 Jul; 59(7):1666-1671. PubMed ID: 29065747 [TBL] [Abstract][Full Text] [Related]
32. High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan. Nieto Y; Valdez BC; Pingali SR; Bassett R; Delgado R; Nguyen J; Shah N; Popat U; Jones RB; Andersson BS; Gulbis A; Ahmed S; Bashir Q; Parmar S; Patel K; Myers A; Rondon G; Orlowski RZ; Champlin R; Qazilbash M Lancet Haematol; 2017 Jun; 4(6):e283-e292. PubMed ID: 28522110 [TBL] [Abstract][Full Text] [Related]
33. Outpatient autologous stem cell transplantation in Royal Hobart Hospital, Tasmania: a single-centre, retrospective review in the Australian setting. Tan XN; Yew CY; Ragg SJ; Harrup RA; Johnston AM Intern Med J; 2022 Jul; 52(7):1242-1250. PubMed ID: 33949777 [TBL] [Abstract][Full Text] [Related]
34. Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes. Christoforidou AV; Saliba RM; Williams P; Qazilbash M; Roden L; Aleman A; Weber D; Mendoza F; Podoloff D; Wendt R; Breitz H; Alexanian R; Champlin R; Giralt S Biol Blood Marrow Transplant; 2007 May; 13(5):543-9. PubMed ID: 17448913 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation. Martino M; Gori M; Porto G; Pellicano M; Santoro L; Verduci C; Canale FA; Loteta B; Moscato T; Alati C; Ieracitano MC; Cuzzocrea A; Altomonte M; Florenzano MT; Morabito A; Irrera G; Naso V; Pugliese M; Console G; Ferreri A; Imbalzano L; Tripepi G; Pitino A Ann Hematol; 2023 Jul; 102(7):1915-1925. PubMed ID: 37079070 [TBL] [Abstract][Full Text] [Related]
36. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma. Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951 [TBL] [Abstract][Full Text] [Related]
37. Autologous stem cell transplantation in multiple myeloma patients with renal impairment. Zhai Y; Yan L; Jin S; Yan S; Yao W; Shang J; Shi X; Wang R; Kang H; Lu J; Zhu Z; Tang F; Wei F; Fu C; Wu D Ann Hematol; 2023 Mar; 102(3):621-628. PubMed ID: 36633638 [TBL] [Abstract][Full Text] [Related]
38. Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma. Miyamoto T; Yoshimoto G; Kamimura T; Muta T; Takashima S; Ito Y; Shiratsuchi M; Choi I; Kato K; Takenaka K; Iwasaki H; Takamatsu Y; Teshima T; Akashi K Int J Hematol; 2013 Sep; 98(3):337-45. PubMed ID: 23877150 [TBL] [Abstract][Full Text] [Related]
39. A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant. Martino M; Gori M; Tripepi G; Recchia AG; Cimminiello M; Provenzano PF; Naso V; Ferreri A; Moscato T; Console G; Loteta B; Gallo GA; Gentile M; Innao V; Rossi M; Morabito A; Vincelli ID; Mannina D; Pitino A Ann Hematol; 2020 Feb; 99(2):331-341. PubMed ID: 31853703 [TBL] [Abstract][Full Text] [Related]
40. Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. Rodriguez TE; Hari P; Stiff PJ; Smith SE; Sterrenberg D; Vesole DH Biol Blood Marrow Transplant; 2016 Aug; 22(8):1391-1396. PubMed ID: 27164062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]